Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thyroid disorders induced by immune checkpoint inhibitors
Dimitra Karaviti, Eleni-Rafaela Kani, Eleftheria Karaviti, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 67-79
Open Access | Times Cited: 11

Showing 11 citing articles:

Case report: Multi-organ injuries induced by tislelizumab
Man Yuan, Ning Han, Shu Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review
Chiara Pozzessere, Bianca Mazini, Patrick Omoumi, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2585-2585
Open Access | Times Cited: 6
Association between platelet-to-lymphocyte ratio and immune checkpoint inhibitor-induced thyroid dysfunction
Wang Ai, Huijie Huang, Yangli Chen, et al.
Endocrine (2025)
Closed Access
Real-World Evaluation of Immune-Related Endocrinopathies in Metastatic NSCLC Patients Treated with ICIs in Romania
Simona Coniac, Mariana Costache-Outas, Ionuț-Lucian Antone-Iordache, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1198-1198
Open Access
A Scoping Review on the Prevalence of Hashimoto’s Thyroiditis and the Possible Associated Factors
Hernando Vargas‐Uricoechea, Alejandro Castellanos-Pinedo, Karen Urrego-Noguera, et al.
Medical Sciences (2025) Vol. 13, Iss. 2, pp. 43-43
Open Access
Sintilimab combined with anlotinib as first-line treatment for advanced sarcomatoid carcinoma of head and neck: a case report and literature review
Lei Wang, Yingyu Huang, Xin Sun
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Breast cancer and neoplasms of the thyroid gland: a bidirectional two-sample Mendelian randomization study
Yiqi Sun, Ben Wan, Xin Liu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Longitudinal Assessment of FT3 to FT4 Conversion Ratio in Predicting the Efficacy of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small Cell Lung Cancer: A Propensity-Score Matching Analysis of Data from the National Drug Monitoring Agency
Fabrizio Nelli, Enzo Maria Ruggeri, Marta Schirripa, et al.
Current Oncology (2024) Vol. 31, Iss. 12, pp. 7647-7662
Open Access | Times Cited: 1
Serologic predictors of thyroid immune-related adverse events during immune checkpoint inhibitors therapy: a retrospective cohort study
Anastasiya A. Glibka, Н. В. Мазурина, К. А. Саранцева, et al.
Almanac of Clinical Medicine (2024)
Open Access | Times Cited: 1
Management Aspects of Medical Therapy in Graves’ Disease
Rutu Shah, Samantha E. Adamson, Sina Jasim
Endocrine Practice (2024)
Open Access
Immune-related thyroid dysfunction as a positive prognostic factor for patients with lung cancer in China: a real-world retrospective study
Ge Guo, Zihan Jing, Wenbin Dou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top